News: The Latest


Webinar: Clinical Update on BCA101: Overview and Discussion of Newly Presented Data

Bicara Webinar, September 2022

Video Presentation: Bicara Therapeutics Company Overview

Piper Sandler 33rd Annual Virtual Healthcare Conference, November 2021

Poster Presentation: Development of BCA101, a Bifunctional Antibody Capable of Simultaneously Disabling EGFR and TGF-β Signaling, as a Novel Single-agent Immunotherapy

Society for Immunotherapy of Cancer (SITC) 2021 Annual Meeting, November 2021

Digital Presentations: First-in-human Phase I Study of the Bifunctional EGFR/TGFβ Fusion Protein BCA101 in Patients with EGFR-driven Advanced Solid Cancers

American Society of Clinical Oncology, June 2021